Relmada Therapeutics, Inc. (RLMD)
2.90
-0.21
(-6.75%)
USD |
NASDAQ |
Nov 20, 10:47
Relmada Therapeutics Cash from Investing (Quarterly) : 6.954M for Sept. 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 6.954M |
| June 30, 2026 | 17.59M |
| March 31, 2026 | -135.23M |
| December 31, 2025 | -76.93M |
| September 30, 2025 | 6.753M |
| June 30, 2025 | 6.678M |
| March 31, 2025 | 15.36M |
| December 31, 2024 | 11.35M |
| September 30, 2024 | 16.14M |
| June 30, 2024 | 14.01M |
| March 31, 2024 | 10.06M |
| December 31, 2023 | 7.741M |
| September 30, 2023 | 3.860M |
| June 30, 2023 | -1.152M |
| March 31, 2023 | 40.00M |
| December 31, 2022 | -1.655M |
| September 30, 2022 | 31.56M |
| June 30, 2022 | -0.1405M |
| March 31, 2022 | -10.03M |
| December 31, 2021 | -91.18M |
| September 30, 2021 | 27.51M |
| June 30, 2021 | -5.912M |
| March 31, 2021 | 15.47M |
| December 31, 2020 | 0.9353M |
| September 30, 2020 | 4.588M |
| Date | Value |
|---|---|
| June 30, 2020 | -16.34M |
| March 31, 2020 | -23.63M |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | -0.0098M |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | -0.0026M |
| June 30, 2017 | -0.0022M |
| March 31, 2017 | -0.0202M |
| December 31, 2016 | -0.0024M |
| September 30, 2016 | -0.0248M |
| June 30, 2016 | -0.023M |
| March 31, 2016 | -0.0631M |
| December 31, 2015 | -0.4748M |
| September 30, 2015 | -0.0013M |
| June 30, 2015 | -0.0039M |
| March 31, 2015 | -0.0023M |
| December 31, 2014 | -0.0065M |
| September 30, 2014 | -0.0107M |
| August 31, 2014 | |
| May 31, 2014 | |
| February 28, 2014 | 0.0008M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Talphera, Inc. | 12.92M |
| Journey Medical Corp. | 0.00 |
| ANI Pharmaceuticals, Inc. | -13.50M |
| Corcept Therapeutics, Inc. | -131.99M |
| Veru, Inc. | 1.802M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -12.59M |
| Cash from Financing (Quarterly) | 0.0177M |
| Free Cash Flow | -51.86M |
| Free Cash Flow Per Share (Quarterly) | -0.1119 |
| Free Cash Flow to Equity (Quarterly) | -12.59M |
| Free Cash Flow to Firm (Quarterly) | -12.59M |
| Free Cash Flow Yield | -16.76% |